Research progression in clinical treatment of gastric cancer in 2020.
10.3760/cma.j.cn.441530-20201225-00682
- VernacularTitle:2020年胃癌临床诊治研究进展
- Author:
Xin Yu QIN
1
Author Information
1. Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Publication Type:Journal Article
- Keywords:
Gastric cancer;
Immunotherapy;
Laparoscopic surgery;
Perioperative chemotherapy
- MeSH:
Biomedical Research/trends*;
Combined Modality Therapy;
Gastrectomy;
Humans;
Prognosis;
Quality of Life;
Stomach Neoplasms/therapy*
- From:
Chinese Journal of Gastrointestinal Surgery
2021;24(1):23-26
- CountryChina
- Language:Chinese
-
Abstract:
Gastric cancer is a common type of malignant tumors, but its clinical prognosis remains unsatisfactory. Up to 2020, a growing number of high-quality clinical researches has provided reliable evidence for clinical practice. Evidences from surgery, perioperative treatment and immunotherapy, such as changes in surgical methods, improvement of perioperative chemotherapy and combination of immune and chemotherapy strategy, provided the possibility to improve the clinical efficacy of gastric cancer. In our clinical practice, gastrointestinal surgeons need to integrate the current research progression and develop individualized strategy for different patients, which is expected to further improve the prognosis and quality of life for patients with gastric cancer.
